Peptide

Octreotide

FDA-approved product existsGH axis & hormones
Not yet scored

BioHarmony verdict

Awaiting review

No BioHarmony report yet. It is queued for review; until then, rely on the status and sources below.

Dosing as published

No approved-label or study protocol is recorded for Octreotide yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingFDA-approved products exist; compounded copies are not FDA approved
Last checked2026-07-13
Next review2026-10-11 (overdue, details paused)

Primary sources

Sources are still being reviewed for this compound.

  1. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
  2. 6.8/10Gonadorelin (GnRH)Worth tryingGH & hormonesFDA-approved product existsGonadorelin is synthetic GnRH, a decapeptide that tells the pituitary to release LH and FSH.
  3. 6.5/10Kisspeptin-10Worth tryingGH & hormonesNot FDA approvedKisspeptin-10 is an investigational reproductive neuropeptide that activates the HPG axis through the KISS1R receptor.
  4. 6.2/10IpamorelinWorth tryingRecoveryNot FDA approvedIpamorelin is a selective growth-hormone secretagogue with strong receptor selectivity but almost no human efficacy data: its only completed human efficacy trial…

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.